Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-12

FDA Approved: EPINEPHRINE — Supplemental Application (BPI Labs, LLC)

View source ↗

Summary

FDA approved a supplemental application for Epinephrine from BPI Labs, LLC. This marks an additional regulatory authorization for Epinephrine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPINEPHRINE (EPINEPHRINE)

Snippet

SUPPL AP for EPINEPHRINE (EPINEPHRINE)